Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)
暂无分享，去创建一个
C. Bokemeyer | A. Hinke | A. Stein | S. Al-Batran | D. Pink | E. Goekkurt | T. Ettrich | M. Binder | S. Lorenzen | S. Hegewisch‐Becker | P. Thuss-Patience | A. Kretzschmar | L. Jacobasch | S. Nilsson | J. Tintelnot | U. Lindig | J. R. Knorrenschild